申请人:NeuroVive Pharmaceutical AB
公开号:US20140234414A1
公开(公告)日:2014-08-21
There is provided inter alia a pharmaceutical dosage form for oral administration comprising a sanglifehrin as active ingredient in which the sanglifehrin active ingredient is protected from acid degradation in the stomach environment following oral administration.
提供了一种用于口服的药物剂型,包括桑格利非林作为活性成分,其中桑格利非林活性成分在口服后受到胃酸降解的保护。